The Price Is Right For Oxford Nanopore Technologies plc (LON:ONT)
Dec 19
Have your own idea? Try our Stock Screener
U.K. (FTSE) Healthcare Sector Analysis
UpdatedJan 17, 2025
DataAggregated Company Financials
Companies92
- 7D-0.6%
- 3M-8.6%
- 1Y-1.7%
- YTD1.6%
Last week, the Healthcare industry hasn't moved much but ConvaTec Group is up 6.0% in that time. In line with that, the industry has also been flat over the past 12 months. Earnings are forecast to grow by 19% annually.
Sector Valuation and Performance
Has the U.K. Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Fri, 17 Jan 2025 | UK£253.8b | UK£87.3b | UK£7.8b | 30.2x | 32.6x | 2.9x |
| Sun, 15 Dec 2024 | UK£246.5b | UK£85.7b | UK£7.6b | 30.1x | 32.4x | 2.9x |
| Tue, 12 Nov 2024 | UK£241.0b | UK£83.2b | UK£7.5b | 26.7x | 32.3x | 2.9x |
| Thu, 10 Oct 2024 | UK£273.0b | UK£82.6b | UK£8.9b | 29x | 30.7x | 3.3x |
| Sat, 07 Sep 2024 | UK£295.7b | UK£82.1b | UK£8.8b | 32.8x | 33.4x | 3.6x |
| Mon, 05 Aug 2024 | UK£291.1b | UK£83.2b | UK£8.9b | 33x | 32.6x | 3.5x |
| Wed, 03 Jul 2024 | UK£282.4b | UK£81.8b | UK£9.4b | 29.8x | 30x | 3.5x |
| Fri, 31 May 2024 | UK£287.7b | UK£81.6b | UK£9.4b | 32.2x | 30.7x | 3.5x |
| Sun, 28 Apr 2024 | UK£283.4b | UK£82.1b | UK£9.9b | 30.2x | 28.5x | 3.5x |
| Tue, 26 Mar 2024 | UK£263.5b | UK£81.0b | UK£9.6b | 34x | 27.4x | 3.3x |
| Thu, 22 Feb 2024 | UK£255.7b | UK£79.7b | UK£9.4b | 37.6x | 27.1x | 3.2x |
| Sat, 20 Jan 2024 | UK£272.9b | UK£84.0b | UK£10.6b | 38.8x | 25.7x | 3.2x |
| Mon, 18 Dec 2023 | UK£261.7b | UK£84.1b | UK£10.7b | 40.2x | 24.5x | 3.1x |
| Wed, 15 Nov 2023 | UK£259.5b | UK£84.8b | UK£10.7b | 41.6x | 24.2x | 3.1x |
| Fri, 13 Oct 2023 | UK£281.4b | UK£86.0b | UK£10.3b | 40.4x | 27.4x | 3.3x |
| Sun, 10 Sep 2023 | UK£275.6b | UK£84.9b | UK£10.2b | 40.2x | 27x | 3.2x |
| Tue, 08 Aug 2023 | UK£273.6b | UK£83.8b | UK£10.1b | 43.4x | 27x | 3.3x |
| Thu, 06 Jul 2023 | UK£268.7b | UK£82.7b | UK£7.9b | 43.4x | 34.1x | 3.3x |
| Sat, 03 Jun 2023 | UK£286.7b | UK£83.5b | UK£8.0b | 48.4x | 35.9x | 3.4x |
| Mon, 01 May 2023 | UK£291.6b | UK£83.1b | UK£7.9b | 48.6x | 36.8x | 3.5x |
| Wed, 29 Mar 2023 | UK£276.2b | UK£84.6b | UK£7.0b | 39.9x | 39.7x | 3.3x |
| Fri, 24 Feb 2023 | UK£282.7b | UK£85.6b | UK£7.2b | 44.1x | 39.1x | 3.3x |
| Sun, 22 Jan 2023 | UK£281.7b | UK£94.0b | UK£6.5b | 36x | 43x | 3x |
| Tue, 20 Dec 2022 | UK£278.3b | UK£94.8b | UK£6.6b | 36.6x | 42.2x | 2.9x |
| Thu, 17 Nov 2022 | UK£270.9b | UK£95.9b | UK£6.7b | 33.4x | 40.6x | 2.8x |
| Sat, 15 Oct 2022 | UK£496.7b | UK£96.5b | UK£4.0b | 27.4x | 124.4x | 5.1x |
| Mon, 12 Sep 2022 | UK£267.2b | UK£94.8b | UK£4.1b | 37.7x | 65.7x | 2.8x |
| Wed, 10 Aug 2022 | UK£285.2b | UK£92.7b | UK£4.0b | 35.6x | 70.4x | 3.1x |
| Fri, 08 Jul 2022 | UK£311.9b | UK£90.0b | UK£4.9b | 34.7x | 63.5x | 3.5x |
| Sun, 05 Jun 2022 | UK£299.2b | UK£88.1b | UK£5.0b | 28.8x | 60.2x | 3.4x |
| Tue, 03 May 2022 | UK£310.2b | UK£88.6b | UK£5.0b | 31.8x | 61.7x | 3.5x |
| Thu, 31 Mar 2022 | UK£298.1b | UK£80.9b | UK£5.1b | 36.1x | 58.4x | 3.7x |
| Sat, 26 Feb 2022 | UK£132.4b | UK£52.1b | UK£5.1b | 31.2x | 26.2x | 2.5x |
| Mon, 24 Jan 2022 | UK£280.3b | UK£75.3b | UK£6.0b | 33x | 46.5x | 3.7x |
Price to Earnings Ratio
46.5x
Current Industry PE
- Investors are pessimistic on the British Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 32.6x which is lower than its 3-year average PE of 42.1x.
- The 3-year average PS ratio of 3.3x is higher than the industry's current PS ratio of 2.9x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have grown 8.9% per year over the last three years.
- Revenues for these companies have grown 5.1% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Trends
Which industries have driven the changes within the U.K. Healthcare sector?
| GB Market | 0.96% | |
| Healthcare | -0.61% | |
| Life Sciences | 7.81% | |
| Biotech | 7.56% | |
| Medical Equipment | 3.49% | |
| Healthcare Services | 1.70% | |
| Healthtech | -0.17% | |
| Pharma | -1.05% | |
Industry PE
- Investors are most optimistic about the Medical Equipment industry even though it's trading below its 3-year average PE ratio of 92.3x.
- Analysts are expecting annual earnings growth of 22.4%, which is lower than the prior year's growth of 39.9% per year.
Forecasted Growth
- Analysts are most optimistic on the Biotech industry, expecting annual earnings growth of 38% over the next 5 years.
- This is better than its past earnings decline of 40% per year.
- In contrast, the Pharma industry is expected to see its earnings grow by 18% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| GSK GSK | UK£13.59 | 0.7% +UK£387.7m | -13.1% | PE22.1x | |
| CTEC ConvaTec Group | UK£2.42 | 7.7% +UK£352.0m | -1.3% | PE39.4x | |
| SN. Smith & Nephew | UK£10.26 | 3.8% +UK£327.0m | -6.7% | PE35.8x | |
| GNS Genus | UK£18.02 | 21.9% +UK£212.8m | -19.1% | PE149.8x | |
| HIK Hikma Pharmaceuticals | UK£20.86 | 3.2% +UK£141.9m | 7.8% | PE19.8x |
